UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cell-free translation of messenger RNAs from human muscle biopsies: a miniaturized tool for investigation of neuromuscular diseases

Pediatric research, 1982-05, Vol.16 (5), p.335-339

1982

Volltextzugriff (PDF)

Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques

Annals of human genetics, 1981-05, Vol.45 (2), p.113-120

1981

Volltextzugriff (PDF)

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

Journal of clinical oncology, 2013-07, Vol.31 (19), p.2428-2436

2013

Volltextzugriff (PDF)

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3322-3327

2011

Volltextzugriff (PDF)

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Leukemia, 2011-07, Vol.25 (7), p.1147-1152

2011

Volltextzugriff (PDF)

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

Haematologica (Roma), 2010-03, Vol.95 (3), p.415-423

2010

Volltextzugriff (PDF)

Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes

Leukemia, 2013-10, Vol.27 (10), p.1981-1987

2013

Volltextzugriff (PDF)

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Haematologica (Roma), 2009-12, Vol.94 (12), p.1676-1681

2009

Volltextzugriff (PDF)

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

Leukemia, 2010-05, Vol.24 (5), p.1094-1096

2010

Volltextzugriff (PDF)

High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9227-9233

2005

Volltextzugriff (PDF)

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Leukemia, 2014-12, Vol.28 (12), p.2367-2375

2014

Volltextzugriff (PDF)

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease

Nature Medicine, 2020-03, Vol.26 (3), p.398-407

2020

Volltextzugriff (PDF)

Prevalence of insomnia in a survey of 12 778 adults in France

Journal of sleep research, 2000-03, Vol.9 (1), p.35-42

2000

Volltextzugriff (PDF)

Risk of infection and associated influenza-like disease among abattoir workers due to two Leptospira species

Epidemiology and infection, 2015-07, Vol.143 (10), p.2095-2105

2015

Volltextzugriff (PDF)

Antegrade cerebral perfusion with cold blood: a 13-year experience

The Annals of thoracic surgery, 1999-06, Vol.67 (6), p.1874-1878

1999

Volltextzugriff (PDF)

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Cancer epidemiology, biomarkers & prevention, 2012-01, Vol.21 (1), p.134-147

2012

Volltextzugriff (PDF)

Risk factors for new infection with Leptospira in meat workers in New Zealand

Occupational and environmental medicine (London, England), 2015-03, Vol.72 (3), p.219-225

2015

Volltextzugriff (PDF)

A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse

Leukemia, 2013-07, Vol.27 (7), p.1479-1486

2013

Volltextzugriff (PDF)

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

Haematologica (Roma), 2012-02, Vol.97 (2), p.213-218

2012

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(144)

Sprache

Englisch
(129)
Französisch
(15)

Erscheinungsjahr

n.n

Thema

Humans
(144)
Female
(123)
Science & Technology
(120)
Life Sciences & Biomedicine
(117)
Male
(113)
Adult
(108)
Aged
(92)
Biological And Medical Sciences
(70)
Medical Sciences
(70)
Hematology
(57)
Oncology
(38)
Aged, 80 And Over
(36)
Adolescent
(35)
Hematologic And Hematopoietic Diseases
(32)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(32)
Treatment Outcome
(32)
Life Sciences
(27)
Follow-Up Studies
(24)
Prognosis
(23)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(144)
Journals@Ovid
(89)
IngentaConnect
(53)
NUS Single-Journal Subscriptions
(50)
Nature Journals
(32)
Nexis Uni
(29)
Wiley Online Library Journals
(26)
IngentaConnect Journals
(26)
Wiley Online Library
(25)
Elsevier ScienceDirect Journals Complete
(16)
Oxford journals
(11)
Oxford Journals 2020 Medicine
(10)
BMJ
(4)
SpringerLink E-Journals
(3)
BMJ Journals Archiv - DFG Nationallizenzen
(3)
JSTOR
(2)
Cambridge Journals Online (DEFF)
(1)
Springer Book Series
(1)

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cell-free translation of messenger RNAs from human muscle biopsies: a miniaturized tool for investigation of neuromuscular diseases

Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group

High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease

Prevalence of insomnia in a survey of 12 778 adults in France

Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM)

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine

Risk of infection and associated influenza-like disease among abattoir workers due to two Leptospira species

Antegrade cerebral perfusion with cold blood: a 13-year experience

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Health, economic, and quality-of-life effects of erythropoietin and granulocyte colony-stimulating factor for the treatment of myelodysplastic syndromes: a randomized, controlled trial

Risk factors for new infection with Leptospira in meat workers in New Zealand

A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse

Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies

Aktive Filter

Suchergebnisse filtern